Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway

We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity in monocyte/macrophage models and induces ERK signalling. In the present study we investigated whether MBZ induced ERK activation is shared by other tubulin binding agents (TBAs) and if it is observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Claes R., Selvin, Tove, Blom, Kristin, Rubin, Jenny, Berglund, Malin, Jarvius, Malin, Lenhammar, Lena, Parrow, Vendela, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403428/
https://www.ncbi.nlm.nih.gov/pubmed/32753665
http://dx.doi.org/10.1038/s41598-020-68986-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403428/
https://www.ncbi.nlm.nih.gov/pubmed/32753665
http://dx.doi.org/10.1038/s41598-020-68986-0

Ejemplares similares